Jump to Main Content

2024 Highlights of ASH®

Highlights of ASH in Asia-Pacific

Join the world's leading hematology experts at Highlights of ASH in Asia-Pacific, a two-day program that highlights the most influential research presented at the latest ASH annual meeting, the premier event in malignant and non-malignant hematology.

By attending Highlights of ASH, you will get a comprehensive review of significant scientific updates in clinical and translational hematologic research, learn how these updates directly affect the study and practice of hematology, and discover how new research can be translated into cutting-edge patient care.

Through participation in this meeting, you will be able to:

  • Recap stand-out abstracts from the most recent ASH annual meeting.
  • Discuss rapidly evolving developments in hematology and hematology-oncology with leading faculty in the field.
  • Participate in interactive panel discussions and attend small group lunch sessions with the experts.
  • Improve therapeutic and overall practice methods.
  • Discover new treatments for patients.

This meeting has been designed to be a rewarding educational event for hematologists, oncologists, fellows and trainees, allied health professionals, and hematopathologists.

Program Co-Host

ASH is proud to co-host this meeting with the Haematology Society of Australia and New Zealand.

Program Schedule

8:00 a.m. Registration and Exhibition Opens
8:45 a.m. Welcome & Morning Session
9:00 a.m. Clonal Hematopoiesis and Myelodysplastic Syndromes

Radhika Gangaraju, MD
University of Alabama at Birmingham
9:30 a.m. Myeloproliferative Neoplasms Including Chronic Myeloid Leukemia

David Ross, PhD
Flinders Medical Centre
10:00 a.m. Panel Discussion
10:30 a.m. Coffee Break and Exhibition
11:00 a.m. Autoimmunity and Complement Disorders

Hanny Al-Samkari, MD
Harvard University
11:30 a.m. Inherited Bleeding Disorders

Tyler Buckner, MD
University of Colorado, Denver
12:00 p.m. Panel Discussion
12:30 p.m. Lunch with the Experts Session
1:30 p.m. Special Education Session: Hematology in Special Groups

Julie Jaffray, MD
Rady Children's Hospital, San Diego

Michelle Sholzberg, MDCM
St. Michael's Hospital

Yazan Abou-Ismail, MD
University of Utah
2:30 p.m. Nosocomial Hematological Complications

Lana Castellucci, MD
University of Ottawa
3:00 p.m. Panel Discussion
3:30 p.m. Coffee Break and Exhibition
4:00 p.m. Diagnosis, Management, and Treatment of VTE

Neil Zakai, MD
University of Vermont
4:30 p.m. Hemoglobinopathies

John Rasko, AO
Centenary Institute
Royal Prince Alfred Hospital
5:00 p.m. Panel Discussion
5:30 p.m. Highlights of ASH Day 1 Program Adjournment
6:00 p.m.

Satellite Symposia:

Addressing the Challenges of Inhibitors in Haemophilia: A New Era in Non-Factor Replacement Therapy

Unfolding Advanced Light Chain (AL) Amyloidosis: From Diagnostic Challenges to Emerging Therapies

How I approach CLL and MCL treatment in the Era of Novel Therapies (an Australian View)

8:00 a.m. Registration and Exhibition Opens
8:45 a.m. Welcome and Introductions
9:00 a.m. Transfusion Medicine: Blood Banking and Apheresis

Erica Wood, AO
Monash University
9:30 a.m. Hematopoietic Stem Cell Transplantation

John Magenau, MD
University of Michigan
10:00 a.m. Panel Discussion
10:30 a.m. Coffee Break and Exhibition
11:00 a.m. Special Education Session: CAR T- Cell Therapy

Matthew Frank, MD
Stanford University

Loretta Nastoupil, MD
MD Anderson Cancer Center

Robin Sanderson, PhD
King's College London
12:30 p.m. Lunch with the Experts Session
1:30 p.m. Aggressive Non-Hodgkin Lymphoma (Including CAR T-cell Therapy)

Laurie Sehn, MD
University of British Columbia
2:00 p.m.
Low-Grade Lymphoma
(Including Chronic Lymphoid Leukemia)

Adam Kittai, MD
Ohio State University
2:30 p.m. Panel Discussion
3:00 p.m Coffee Break and Exhibition
3:30 p.m. Acute Lymphoblastic Leukemia

William Stevenson, PhD
Royal North Shore Hospital
4:00 p.m. Acute Myeloid Leukemia

Andrew Wei, PhD
Peter Maccallum Cancer Centre
4:30 p.m. Myeloma & Plasma Cell Dyscrasia

P. Joy Ho, MBBS, DPhil
Royal Prince Alfred Hospital
University of Sydney
5:00 p.m. Panel Discussion
5:30 p.m Meeting Adjournment

View Faculty Disclosure Information

The American Society of Hematology would like to acknowledge the following companies for the educational grants provided in support of the 2024 Highlights of ASH ® in Asia-Pacific.

  • AstraZeneca
  • Novo Nordisk
  • Prothena